FPR3 and central nervous system cancer: Through scRNA sequencing, we were able to identify FPR3 expression in malignant cells as well as immune cells like CD8Tex cells, dendritic cells (DC), and macrophages within BRCA, glioma, GBM, LIHC, NSCLC, and SKCM samples (Figure 1C).